Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 and Asthma: Reflection During the Pandemic
Shuang Liu, Yuxiang Zhi, Sun Ying
Clinical Reviews in Allergy & Immunology (2020) Vol. 59, Iss. 1, pp. 78-88
Open Access | Times Cited: 196

Showing 51-75 of 196 citing articles:

Impact of Anti-Type 2 Inflammation Biologic Therapy on COVID-19 Clinical Course and Outcome
Dimitri Poddighe, Elena Kovzel
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 6845-6853
Open Access | Times Cited: 23
Asthma in patients with suspected and diagnosed coronavirus disease 2019
Lijuan Cao, Charles Lee, James G. Krings, et al.
Annals of Allergy Asthma & Immunology (2021) Vol. 126, Iss. 5, pp. 535-541.e2
Open Access | Times Cited: 21
Frequency of asthma exacerbation in children during the coronavirus disease pandemic with strict mitigative countermeasures
Huifeng Fan, Chunhui He, Genquan Yin, et al.
Pediatric Pulmonology (2021) Vol. 56, Iss. 6, pp. 1455-1463
Closed Access | Times Cited: 21
Inhaled corticosteroids for the treatment of COVID-19
Mona Bafadhel, Rosa Faner, Camille Taillé, et al.
European Respiratory Review (2022) Vol. 31, Iss. 166, pp. 220099-220099
Open Access | Times Cited: 15
Omalizumab may protect allergic patients against COVID-19: A systematic review
Daniele Giovanni Ghiglioni, Laura Cozzi, Riccardo Castagnoli, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 2, pp. 100741-100741
Open Access | Times Cited: 8
Evaluation of the Clinical and Laboratory Findings of Asthmatic Children with SARS-CoV-2 Infection
Azize Pınar Metbulut, Özlem Mustafaoğlu, Gülşah Şen, et al.
International Archives of Allergy and Immunology (2021) Vol. 182, Iss. 10, pp. 989-996
Open Access | Times Cited: 19
COVID-19 and lung pathologies
Darshana Purohit, Ashok Kumar Ahirwar, Apurva Sakarde, et al.
Hormone Molecular Biology and Clinical Investigation (2021) Vol. 42, Iss. 4, pp. 435-443
Closed Access | Times Cited: 18
Genetic variation of allergic disease is associated with the susceptibility to COVID-19
Yaqi Xu, Ran Gao, Gaizhi Zhu, et al.
Journal of Infection (2022) Vol. 84, Iss. 5, pp. e92-e93
Open Access | Times Cited: 12
Insights into potential mechanisms of asthma patients with COVID-19: A study based on the gene expression profiling of bronchoalveolar lavage fluid
Yong Jiang, Qian Yan, Chengxin Liu, et al.
Computers in Biology and Medicine (2022) Vol. 146, pp. 105601-105601
Open Access | Times Cited: 12
Potential Cell-Based and Cell-Free Therapy for Patients with COVID-19
Marselina Irasonia Tan, Nayla Majeda Alfarafisa, Popi Septiani, et al.
Cells (2022) Vol. 11, Iss. 15, pp. 2319-2319
Open Access | Times Cited: 12
A Machine Learning Model for Predicting Hospitalization in Patients with Respiratory Symptoms during the COVID-19 Pandemic
Victor Muniz de Freitas, Daniela Mendes Chiloff, Giulia Gabriella Bosso, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4574-4574
Open Access | Times Cited: 11
Co-Infection Associated with SARS-CoV-2 and Their Management
Vivek P. Chavda, Aayushi Patel, Anjali Pandya, et al.
Future Science OA (2022) Vol. 8, Iss. 9
Open Access | Times Cited: 11
The inflammatory microenvironment of the lung at the time of infection governs innate control of SARS-CoV-2 replication
Paul J. Baker, Andrea C. Bohrer, Ehydel Castro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
The inflammatory microenvironment of the lung at the time of infection governs innate control of SARS-CoV-2 replication
Paul J. Baker, Andrea C. Bohrer, Ehydel Castro, et al.
Science Immunology (2024) Vol. 9, Iss. 102
Open Access | Times Cited: 2
ACE2 in the second act of COVID‐19 syndrome: Peptide dysregulation and possible correction with oestrogen
Limei Zhang, Mario A. Zetter, Enrique C. Guerra, et al.
Journal of Neuroendocrinology (2021) Vol. 33, Iss. 2
Open Access | Times Cited: 15
Implications of Low-grade Inflammation in SARS-CoV-2 Immunopathology
Anamary Suárez-Reyes, Carlos Agustín Villegas Valverde
MEDICC Review (2021) Vol. 23, Iss. 2
Open Access | Times Cited: 15
Comparison of Clinical Characteristics and Outcome Between Vaccinated and Non-Vaccinated Patients of Covid-19 During the Delta Variant-Dominated Fourth Wave in a Tertiary Care Hospital in Karachi, Pakistan
Jamal Azfar Khan, Luqman Satti, Mahwash Bizanjo, et al.
Cureus (2022)
Open Access | Times Cited: 10
Patients with allergic asthma have lower risk of severe COVID-19 outcomes than patients with nonallergic asthma
Thomas Murphy, William W. Busse, Cécile Holweg, et al.
BMC Pulmonary Medicine (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Identification of human genetic variants modulating the course of COVID-19 infection with importance in other viral infections
Lana Salihefendić, Ivana Čeko, Larisa Bešić, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 6
Immune responses and exacerbations in severe asthma
Matthew Camiolo, Sagar Kale, Timothy B. Oriss, et al.
Current Opinion in Immunology (2021) Vol. 72, pp. 34-42
Open Access | Times Cited: 14
Risk factors associated with the severity of COVID-19 in a region of the Brazilian Amazon
Daniele Melo Sardinha, Rosane do Socorro Pompeu de Loiola, Ana Lúcia da Silva Ferreira, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 14
Immunological Aspects Related to Viral Infections in Severe Asthma and the Role of Omalizumab
Francesco Menzella, Giulia Ghidoni, Carla Galeone, et al.
Biomedicines (2021) Vol. 9, Iss. 4, pp. 348-348
Open Access | Times Cited: 13
Severe asthma in the era of COVID-19: A narrative review
João Gaspar Marques, Mafalda van Zeller, Pedro Martins, et al.
Pulmonology (2021) Vol. 28, Iss. 1, pp. 34-43
Open Access | Times Cited: 13
Effect of Preexisting Asthma on the Risk of ICU Admission, Intubation, and Death from COVID-19: A Systematic Review and Meta-Analysis
Abhinav Bhattarai, Garima Dhakal, Sangam Shah, et al.
Interdisciplinary Perspectives on Infectious Diseases (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 9
Forthcoming complications in recovered COVID-19 patients with COPD and asthma; possible therapeutic opportunities
Hadi Rajabi, Deniz Mortazavi, Nur Konyalılar, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 9

Scroll to top